Comprehensive Catalog of Clinically Significant Somatic and Germline Variants in the RET Oncogene for Medullary Thyroid Carcinoma Patient Management

Presented at The 2024 ACMG Annual Clinical Genetics Meeting by Genomenon Founder and Chief Scientific Officer, Mark Kiel, MD, PhD.

The World’s Most Comprehensive Source of Genomic Evidence

Mastermind accelerates variant interpretation with immediate insight into the full text of millions of scientific articles. Prioritize your search results by clinical relevance and find what you are looking for 5-10 times faster

Explore Mastermind CORE
Every Missing Genetic Variant is a Patient Your Label Doesn't Reach
  • Rare disease and precision oncology programs rely on evidence fragmented across millions of published articles and supplemental datasets.
  • Genomenon builds the custom real-world evidence your program needs.
  • AI-powered search. Expert scientific curation.
  • The result: a broader label, more eligible patients, and a regulatory filing your team can defend.
Request a custom evidence build for your program
speak with an expert